ReviewFrontiers in plant science2026
Convergence between light quality and methyl jasmonate signaling in the regulation of betalain biosynthesis.
Review in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Betalains are nitrogen-containing pigments that produce red-violet and yellow-orange coloration in plants of the order Caryophyllales. Owing to their antioxidant, anti-inflammatory and anticancer activities, they have attracted considerable interest as natural food colourants and functional ingredients. Betalain biosynthesis is governed by both developmental programmes and environmental inputs, among which light quality and jasmonate signalling are key regulators. This review systematically examines the independent and synergistic roles of these two signals in controlling betalain production. Exogenous methyl jasmonate (MeJA), a widely used elicitor, is converted intracellularly to the bioactive ligand JA-Ile, which triggers SCF(COI1)-dependent degradation of JAZ repressors, thereby releasing MYC2 and MYC3 to activate downstream transcription. Light quality, operating through specific photoreceptors and the COP1-HY5 module, modulates betalain accumulation in a wavelength- and species-specific manner. Accumulating evidence suggests that both pathways converge on R2R3-MYB transcription factors, which bind MBS motifs in the promoters of the key structural genes CYP76AD1 and DODA. The betalain biosynthetic pathway proceeds through four principal enzymatic steps to yield betacyanins and betaxanthins, catalysed sequentially by ADH, CYP76AD1, DODA and cDOPA5GT. We propose a MYC2-HY5-MYB regulatory axis as a working model for the coordinate regulation of betalain biosynthesis, and identify key questions that remain to be resolved through functional studies in betalain-producing species.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.